Cite
HARVARD Citation
Virlogeux, V. et al. (2014). Boceprevir and telaprevir‐based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end‐stage liver disease score. Journal of viral hepatitis. 21 (9), pp. e98-e107. [Online].